Literature DB >> 29578102

Secondary prevention of chronic musculoskeletal pain: A systematic review of clinical trials.

Caroline Meyer1, Camille M Denis1, Anne D Berquin2.   

Abstract

BACKGROUND: Chronic musculoskeletal pain disorders are highly prevalent and have high personal and societal cost. Hence, early detection and care of patients at risk of developing chronic pain is important. Risk factors are well known and screening tools exist, but much less is known about the care of at-risk patients. The aim of this study was to investigate the effectiveness of secondary prevention strategies for musculoskeletal pain.
METHODS: We performed a systematic review of clinical trials in which treatments were adjusted to the risk of chronicity in adults with acute or subacute musculoskeletal pain. Clinical trials, systematic reviews and meta-analyses published after January 1, 2000 were searched in PubMed and PEDro databases and in the reference list of relevant papers. The risk of bias was assessed by the PEDro score.
RESULTS: We identified 4807 potentially eligible articles; 13, corresponding to 9 studies, met the inclusion criteria. Most studies investigated low back pain. The overall risk of bias was moderate, mainly because of the difficulty of blinding in physiotherapy studies. As compared with a "one-size-fits-all" treatment, stratified programmes showed significant improvements in several domains of the International Classification of Functioning, Disability and Health: body structures and functions (pain, mood), activities (functional capacity), participation (return to work, quality of life), as well as environmental factors (healthcare consumption). Effect sizes were moderate. Overall, simple educational messages seemed sufficient for low-risk patients. Medium- and high-risk patients benefited from a physical reactivation programme combined with education. In high-risk patients, an additional cognitive-behavioural intervention further improved the outcome.
CONCLUSIONS: A stratified approach seems effective in reducing long-term disability in patients with musculoskeletal pain. However, more research is necessary to confirm these results.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chronic pain; Low back pain; Musculoskeletal pain; Secondary prevention; Stratified care

Mesh:

Year:  2018        PMID: 29578102     DOI: 10.1016/j.rehab.2018.03.002

Source DB:  PubMed          Journal:  Ann Phys Rehabil Med        ISSN: 1877-0657


  6 in total

Review 1.  [Pain prevention in the primary care setting : Facts for resident physicians].

Authors:  C Geber; B Kappis; T Bäsch; H R Casser
Journal:  Schmerz       Date:  2021-01-06       Impact factor: 1.107

Review 2.  [Prevention of chronic pain in the German healthcare system : Current state and perspective].

Authors:  Ulrike Kaiser; Bernd Nagel; Frank Petzke; Michael Pfingsten; Anne Gärtner; Thomas Isenberg; Katharina Augustin; Carolin Martin; Gabriele Lindena
Journal:  Schmerz       Date:  2021-01-15       Impact factor: 1.107

3.  Feasibility and long-term efficacy of a proactive health program in the treatment of chronic back pain: a randomized controlled trial.

Authors:  A Hüppe; C Zeuner; S Karstens; M Hochheim; M Wunderlich; H Raspe
Journal:  BMC Health Serv Res       Date:  2019-10-21       Impact factor: 2.655

4.  Patients' Views on the Implementation Potential of a Stratified Treatment Approach for Low Back Pain in Germany: A Qualitative Study.

Authors:  Sven Karstens; Sarah Lang; Benjamin Saunders
Journal:  Health Serv Insights       Date:  2020-12-07

5.  Individuals' beliefs about the biopsychosocial factors that contribute to their chronic musculoskeletal pain: protocol for a qualitative study in the UK.

Authors:  Michael Dunn; Alison B Rushton; Andrew Soundy; Nicola R Heneghan
Journal:  BMJ Open       Date:  2022-07-21       Impact factor: 3.006

6.  Challenges and opportunities in translational pain research - An opinion paper of the working group on translational pain research of the European pain federation (EFIC).

Authors:  André Mouraux; Kirsty Bannister; Susanne Becker; David P Finn; Gisèle Pickering; Esther Pogatzki-Zahn; Thomas Graven-Nielsen
Journal:  Eur J Pain       Date:  2021-02-24       Impact factor: 3.651

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.